Sony Tuteja, Zhihong Yu, Otis Wilson, Hua‐Chang Chen, Frank Wendt, Cecilia P. Chung, . . . the VA Million Veteran Program COVID‐19 Science Initiative. (2022). Pharmacogenetic variants and risk of remdesivir‐associated liver enzyme elevations in Million Veteran Program participants hospitalized with COVID‐19. Wiley.
Chicago Style (17th ed.) CitationSony Tuteja, et al. Pharmacogenetic Variants and Risk of Remdesivir‐associated Liver Enzyme Elevations in Million Veteran Program Participants Hospitalized with COVID‐19. Wiley, 2022.
MLA (9th ed.) CitationSony Tuteja, et al. Pharmacogenetic Variants and Risk of Remdesivir‐associated Liver Enzyme Elevations in Million Veteran Program Participants Hospitalized with COVID‐19. Wiley, 2022.
Warning: These citations may not always be 100% accurate.